Coloplast surpasses guidance and sets out to launch share buyback program
Coloplast's Q1 fiscal report shows better overall results than what analysts expected. The firm also announces its plans to launch a share buyback program worth DKK 500m.
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY NIELSINE NIELSEN
Tuesday morning Danish medtech firm Coloplast presented its Q1 report for the staggered fiscal year 2020/2021, which contained some surprises compared with what analysts had expected.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Ambu will use pandemic to kick in door to new markets
For subscribers
Coloplast CEO urged to take action: Release the billions!
For subscribers
.jpg&w=384&q=75)
